| dbo:abstract |
Lilopristone (INN) (developmental code names ZK-98734, ZK-734) is a synthetic, steroidal antiprogestogen with additional antiglucocorticoid activity which was developed by Schering and was patented in 1985. It is described as an abortifacient and endometrial contraceptive. The drug differs from mifepristone only in the structure of its C17α side chain, and is said to have much reduced antiglucocorticoid activity in comparison. (en) |
| dbo:casNumber |
97747-88-1 |
| dbo:chEMBL |
1908329 |
| dbo:fdaUniiCode |
3GL26H7N6T |
| dbo:pubchem |
13490845 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Lilopristone_skeletal.svg?width=300 |
| dbo:wikiPageID |
53979801 (xsd:integer) |
| dbo:wikiPageLength |
5534 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1107515823 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Endometrium dbr:Onapristone dbr:Antiglucocorticoid dbr:Antiprogestogen dbc:Alkene_derivatives dbc:Conjugated_dienes dbc:Dimethylamino_compounds dbc:Enones dbc:Estranes dbc:Antiglucocorticoids dbr:Steroid dbr:Hormonal_contraception dbr:Aglepristone dbc:Antiprogestogens dbr:International_Nonproprietary_Name dbr:Telapristone dbr:Abortifacient dbc:Abortifacients dbr:Mifepristone dbr:Schering_AG dbr:Toripristone dbr:Side_chain dbr:Synthetic_compound |
| dbp:c |
29 (xsd:integer) |
| dbp:casNumber |
97747 (xsd:integer) |
| dbp:chembl |
1908329 (xsd:integer) |
| dbp:chemspiderid |
11644476 (xsd:integer) |
| dbp:h |
37 (xsd:integer) |
| dbp:iupacName |
-11 (xsd:integer) |
| dbp:n |
1 (xsd:integer) |
| dbp:o |
3 (xsd:integer) |
| dbp:pubchem |
13490845 (xsd:integer) |
| dbp:smiles |
C[C@]12C[C@@H]C5=CC=CNC (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
RCOWGILQXUPXEW-FUSOFXSQSA-N (en) |
| dbp:synonyms |
ZK-98734; ZK-734; 11β--17β-hydroxy-17α-estra-4,9-dien-3-one (en) |
| dbp:unii |
3 (xsd:integer) |
| dbp:width |
250 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Cite_journal dbt:Drugbox dbt:Genito-urinary-drug-stub dbt:Glucocorticoid_receptor_modulators dbt:Progesterone_receptor_modulators dbt:Refbegin dbt:Refend dbt:Reflist dbt:Short_description dbt:Steroid-stub |
| dcterms:subject |
dbc:Alkene_derivatives dbc:Conjugated_dienes dbc:Dimethylamino_compounds dbc:Enones dbc:Estranes dbc:Antiglucocorticoids dbc:Antiprogestogens dbc:Abortifacients |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug |
| rdfs:comment |
Lilopristone (INN) (developmental code names ZK-98734, ZK-734) is a synthetic, steroidal antiprogestogen with additional antiglucocorticoid activity which was developed by Schering and was patented in 1985. It is described as an abortifacient and endometrial contraceptive. The drug differs from mifepristone only in the structure of its C17α side chain, and is said to have much reduced antiglucocorticoid activity in comparison. (en) |
| rdfs:label |
Lilopristone (en) |
| owl:sameAs |
wikidata:Lilopristone https://global.dbpedia.org/id/2YS5s yago-res:Lilopristone |
| prov:wasDerivedFrom |
wikipedia-en:Lilopristone?oldid=1107515823&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Lilopristone_skeletal.svg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Lilopristone |
| is dbo:wikiPageRedirects of |
dbr:ZK-734 dbr:ZK-98,734 dbr:ZK-98734 dbr:ZK734 dbr:ZK98734 dbr:ZK_734 dbr:ZK_98,734 dbr:ZK_98734 |
| is dbo:wikiPageWikiLink of |
dbr:Onapristone dbr:Antiprogestogen dbr:Progesterone_receptor dbr:Aglepristone dbr:Telapristone dbr:Toripristone dbr:List_of_drugs:_Lf–Ln dbr:ZK-734 dbr:ZK-98,734 dbr:ZK-98734 dbr:ZK734 dbr:ZK98734 dbr:ZK_734 dbr:ZK_98,734 dbr:ZK_98734 |
| is foaf:primaryTopic of |
wikipedia-en:Lilopristone |
